Anne C. Regierer - Concepedia

Author

Anne C. Regierer

Charité - Universitätsmedizin Berlin ORCID

Also Known As

A Regierer, A. C. Regierer, A. Regierer, A.C. Regierer, Anne C Regierer, Anne C. Regierer, Anne Constanze Regierer, Anne Regierer, Anne-Constanze Regierer, Hanns-Martin Lorenz

185

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin German Rheumatism Research Centre Heidelberg University University of Bremen Ludwig-Maximilians-Universität München

About

Anne C. Regierer is an author at Charité - Universitätsmedizin Berlin specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	301
2	Health Sciences	1	1	14
3	Nursing	1	1	56
4	Public Health	1	1	19
5	Endocrinology	1	1	36

Anne C. Regierer

Publications

Citations

H-Index

Page 1

	Year	Citations
Biomarkers of depression in cancer patients Christian Jehn, Dagmar Kuehnhardt, Andrea Bartholomae, Cancer	2006	139
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases Rebecca Hasseli, Ulf Müeller-Ladner, Bimba F. Hoyer, RMD Open	2021	118
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. Hongyu Liu, Christian Schölz, Chuanbing Zang, PubMed	2012	101
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project Louise Mercer, Anne C. Regierer, Xavier Mariette, Annals of the Rheumatic Diseases	2017	93
A comparison of international breast cancer guidelines – Do the national guidelines differ in treatment recommendations? R. Wolters, Anne C. Regierer, Lukas Schwentner, European Journal of Cancer NursingBreast OncologyPreventive MedicineHealth PolicyMedicine	2011	56
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines Peter Schmid, Dagmar Kühnhardt, Philipp Kiewe, Annals of Oncology Metastatic Breast CancerBreast OncologyPhase I/ii StudyMedicinePharmacology	2008	52
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD Rebecca Hasseli, Ulf Müeller-Ladner, Tim Schmeiser, RMD Open	2020	48
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients Anne C. Regierer, R. Wolters, M.-P. Ufen, Annals of Oncology Prognostic EvaluationSurgical OncologyMetastatic Breast CancerBreast OncologyMedicine	2013	43
Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle R. Wolters, Lukas Schwentner, Anne C. Regierer, Breast Cancer Research and Treatment ObesityBreast OncologyMedicineGynecologyEndocrine Therapy	2011	36
Metastatic breast cancer: are we treating the same patients as in the past? M.-P. Ufen, C.-H. Köhne, M. Wischneswky, Annals of Oncology Surgical OncologyOncologyMetastatic Breast CancerSame PatientsBreast Oncology	2013	34

Page 1